Global Brachytherapy Market By Type (High-Dose Rate (HDR) brachytherapy, and Low-Dose Rate (LDR) brachytherapy), By Application (Prostate cancer, Breast cancer, and Gynecological cancer), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 138140
- 18-Dec
- PDF/PPT/Word
-
Report Details
Global Brachytherapy Market is estimated to be valued US$ XX.X million in 2019. The report on Brachytherapy Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global brachytherapy market is segmented on the basis of Type, Application, and geography.
Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.
Brachytherapy Market Scope:
By type, the market is segmented into High-Dose Rate (HDR) brachytherapy, and Low-Dose Rate (LDR) brachytherapy. By Application, the market is divided into Prostate cancer, Breast cancer, and Gynecological cancer.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Best Medical International (US), Best Vascular (US), Boston Scientific Corporation (US), COOK Medical (US), C. R. Bard (US), Eckert & Ziegler Strahlen & Medizintechnik AG (Germany), Gammex (US), Nucletron BV (Netherlands), Oncura (US), Sirtex Medical Limited (Australia), Theragenics Corporation (US), Varian Medical Systems (US), and Xoft (US).Key Market Segments
Type
High-Dose Rate (HDR) brachytherapy
Low-Dose Rate (LDR) brachytherapy
Application
Prostate cancer
Breast cancer
Gynecological cancer
Key Market Players included in the report:
Best Medical International (US)
Best Vascular (US)
Boston Scientific Corporation (US)
COOK Medical (US)
C. R. Bard (US)
Eckert & Ziegler Strahlen & Medizintechnik AG (Germany)
Gammex (US)
Nucletron BV (Netherlands)
Oncura (US)
Sirtex Medical Limited (Australia)
Theragenics Corporation (US)
Varian Medical Systems (US)
Xoft (US)
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Brachytherapy Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Brachytherapy Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Brachytherapy Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Brachytherapy Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Brachytherapy Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Brachytherapy Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Brachytherapy sub-markets, depending on key regions (various vital states).
To analyze Brachytherapy Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Brachytherapy Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
Primary worldwide Brachytherapy Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Brachytherapy Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Brachytherapy Market Overview3.1. Brachytherapy Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges 3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global Brachytherapy Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Brachytherapy Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. High-Dose Rate (HDR) brachytherapy4.4. Low-Dose Rate (LDR) brachytherapy5. Global Brachytherapy Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Brachytherapy Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Prostate cancer5.4. Breast cancer
5.5. Gynecological cancer6. Global Brachytherapy Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Brachytherapy Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Brachytherapy Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Brachytherapy Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America Brachytherapy Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Brachytherapy Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Brachytherapy Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Best Medical International (US)7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments 7.4. Best Vascular (US)7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments 7.5. Boston Scientific Corporation (US)7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments 7.6. COOK Medical (US)7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments 7.7. C. R. Bard (US)7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments 7.8. Eckert & Ziegler Strahlen & Medizintechnik AG (Germany)7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments 7.9. Gammex (US)7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments 7.10. Nucletron BV (Netherlands)7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments 7.11. Oncura (US)7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments 7.12. Sirtex Medical Limited (Australia)7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments 7.13. Theragenics Corporation (US)7.13.1. Company Overview
7.13.2. Financial Highlights
7.13.3. Product Portfolio
7.13.4. SWOT Analysis
7.13.5. Key Strategies and Developments 7.14. Varian Medical Systems (US)7.14.1. Company Overview
7.14.2. Financial Highlights
7.14.3. Product Portfolio
7.14.4. SWOT Analysis
7.14.5. Key Strategies and Developments 7.15. Xoft (US)7.15.1. Company Overview
7.15.2. Financial Highlights
7.15.3. Product Portfolio
7.15.4. SWOT Analysis
7.15.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample